Analystreport

Kindred Biosciences (NASDAQ: KIN) had its price target raised by analysts at HC Wainwright to $12.00. They now have a "buy" rating on the stock.

Kindred Biosciences, Inc.  (KIN) 
Last kindred biosciences, inc. earnings: 3/16 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: kindredbio.com/investor-relations